Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US8740602052
12,80 € ↓ -0,10 (-0,78%)
2026-06-04
AKTIENPREIS
SecurityDE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)
InstitutionHighTower Advisors, LLC
Latest Disclosed Ownership103,082 shares
Latest Disclosed Value $ 1,909,061
HighTower Advisors, LLC ownership in TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock)

On May 5, 2026 - HighTower Advisors, LLC filed a 13F-HR form disclosing ownership of 103,082 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) (DE:TKDA) valued at $1,628,696 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 94,828 shares of Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock). This represents a change in shares of 8.70% during the quarter. The current value of the position is $1,319,450 USD.

HighTower Advisors, LLC has a history of taking positions in derivatives of the underlying security (TKDA) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:TKDA / Takeda Pharmaceutical Company Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 103,082 8,254 8.70 1,909 29.16 0.0020
2026-02-06 2025-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 94,828 -4,014 -4.06 1,478 2.14 0.0016
2025-11-07 2025-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 98,842 2,517 2.61 1,447 -2.82 0.0016
2025-08-11 2025-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 96,325 8,580 9.78 1,489 14.19 0.0019
2025-05-13 2025-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 87,745 -36,694 -29.49 1,305 -20.83 0.0018
2025-02-07 2024-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 124,439 1,852 1.51 1,648 -5.56 0.0023
2024-11-14 2024-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 122,587 81,653 199.47 1,744 227.82 0.0025
2024-08-13 2024-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 40,934 -52,123 -56.01 532 -58.98 0.0008
2024-05-06 2024-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 93,057 8,787 10.43 1,297 7.37 0.0021
2024-02-12 2023-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 84,270 550 0.66 1,208 -7.01 0.0020
2023-11-08 2023-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 83,720 12,423 17.42 1,299 16.40 0.0024
2023-08-14 2023-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 71,297 38,651 118.39 1,116 113.38 0.0022
2023-05-12 2023-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 32,646 6,204 23.46 523 26.33 0.0011
2023-02-09 2022-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 26,442 3,015 12.87 414 36.18 0.0009
2022-11-09 2022-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 23,427 -719 -2.98 304 -10.59 0.0008
2022-08-10 2022-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 24,146 -4,180 -14.76 340 -15.84 0.0009
2022-05-12 2022-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 28,326 1,973 7.49 404 12.22 0.0009
2022-02-10 2021-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 26,353 -5,260 -16.64 360 -29.69 0.0008
2021-11-12 2021-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 31,613 -611 -1.90 512 -5.88 0.0014
2021-08-06 2021-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 32,224 5,666 21.33 544 12.16 0.0016
2021-05-10 2021-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 26,558 3,694 16.16 485 16.59 0.0015
2021-02-10 2020-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 22,864 -1,734 -7.05 416 -5.45 0.0017
2020-11-13 2020-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 24,598 889 3.75 440 3.53 0.0021
2020-08-10 2020-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 23,709 4,694 24.69 425 45.05 0.0023
2020-05-21 2020-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 19,015 3,395 21.73 293 -5.18 0.0019
2020-02-14 2019-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 15,620 -454 -2.82 309 12.36 0.0018
2019-11-12 2019-09-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 16,074 -13,865 -46.31 275 -48.50 0.0015
2019-08-13 2019-06-30 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 29,939 919 3.17 534 -9.64 0.0032
2019-05-15 2019-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS 874060205 29,020 29,020 591 0.0039
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-05-11 2022-03-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-10 2021-12-31 13F TAKEDA PHARMACEUTICAL SPONSORED ADS Put 10 1 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.